期刊文献+

无标签NT-proBNP重组蛋白的获得及多克隆抗体的制备 被引量:2

Preparation of tag-free NT-proBNP recombinant protein and its polyclonal antibody
下载PDF
导出
摘要 目的通过原核表达,获得不带标签的NT-proBNP重组蛋白,并用其免疫新西兰大白兔,制备兔抗NT-proBNP抗体。方法从重组菌pET-32a(+)-NT-proBNP提取重组质粒,通过PCR扩增出目的 DNA片段,插入pCold TF载体,转化入大肠埃希菌BL21(DE3),经IPTG诱导表达融合蛋白。经镍柱亲和纯化、HRV 3C蛋白酶酶切、镍柱亲和纯化,制备不带标签的纯蛋白质,并用临床商品化试剂盒验证其抗原性。用该蛋白质免疫新西兰大白兔制备抗体,western blot鉴定其特异性。结果成功获得高纯度的不带标签的NT-proBNP蛋白,该蛋白质能被商品化的试剂盒识别。用该蛋白质免疫新西兰大白兔成功制备出高效价高特异的抗体。结论成功制备高纯度的无标签NT-proBNP蛋白及其多克隆抗体,为NT-proBNP在临床上的广泛应用奠定了基础。 Objective To express tag-free N-terminal pro-B-type natriuretic peptide (NT-proBNP) by prokaryotic expression system and prepare polycolonal antibodies against the recombinant NT-proBNP. Methods NT-proBNP gene sequence was obtained from pET- 32a ( + )-NT-proBNP and inserted into pCold TF vector. The recombinant pCold TF-NT-proBNP was transferred into E. coli BI21 (DE3) and the recombinant NT-proBNP was expressed by IPTG induction. Subsequently, the recombinant NT-proBNP was purified by Nickel affinity column, and further digested with HRV 3C protease. After purification with Nickel affinity column again, tag-free recombinant NT-proBNP was obtained and its antigenicity was analyzed with the commercial kit employed in clinical test. Polyclonal antibodies against the recombinant tag-freeNT-proBNP were prepared by immunizing rabbits and the specificity of antibodies was tested by Western blot. Results Highly purified tag-free NT-proBNP protein was prepared and could be detectable by Roche NT-proBNP test kit. The polyclonal antibodies against recombinant tag-free NT-proBNP with high titer and specificity were also prepared. Conclusion Highly purified tag-free recombinant NT-proBNP protein and its specific polyclonal antibodies were successfully prepared for clinical research of NT-proBNP and widespread application in diagnosis.
出处 《临床检验杂志》 CAS CSCD 北大核心 2012年第11期902-905,共4页 Chinese Journal of Clinical Laboratory Science
基金 重庆市教委课题(KJ120318)
关键词 N末端B型钠尿肽原 原核表达 蛋白质纯化 多克隆抗体 N-terminal pro-B-type natriuretic peptide prokaryotic expression protein purification polyclonal antibody
  • 相关文献

参考文献6

二级参考文献52

  • 1YUAN XIN HU, Ju YUAN QUO, Lu SHEN, YAN CHEN, Zu CHUAN ZHANG, YONG LIAN ZHANGState Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Road,.Get effective polyclonal antisera in one month[J].Cell Research,2002,12(2):157-160. 被引量:45
  • 2Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Namre, 1988,332(3) :78-81.
  • 3McDonagh T A,Robb S D, Murdoch D R, et al. Biochemical detection of left-ventricular systolic dysfunction[J]. Lancet, 1998(1 ) ,351:9-13.
  • 4Valli N, Gobinet A,Bordenave L,et al.Review of 10 year d the clinical use of brain natriuretic peptide in cardiology[J]. J Lab Clin Med, 1999,134(5) :437-444.
  • 5Clerico A, Del Ry S, Giannessi D, et al. Measurement of cardiac natriuretic hormones (atrial natrietic peptide, brain natriuretic peptide,and related peptides)in clinical practice: the need for a new generation of immunoassay methods[ J]. Clin Chem 2000,46(10) : 1529-1534.
  • 6Peacock W F.The B-type natriuretic peptide assay:a rapid test for heart failure[J]. Cleve Clin J Med,2002,69(3):243-251.
  • 7Cowie M R. BNP: soon to become a routine measure in the care of patients with heart failure[J]. Heart,2000,83(6):617-618.
  • 8Kim S D, Piano M R.The natriuretic peptides: physiology and role in leftventricular dysfunction[J]. Biol Res Nurs 2000,2( 1 ) : 15-29.
  • 9McDonagh T A. Asymptomatic left ventricular dysfunction in the community[J]. Curt Cardiol Rep,2000,2(5) :470-474.
  • 10Cowie M R, Mendez G F. BNP and congestive heart failure[J]. Prog Cardiovase Dis,2002,44(4) :293-321.

共引文献65

同被引文献14

  • 1陈翠珠,徐英春,王澎,杨启文,谢秀丽,陈民钧.1557株酵母菌的鉴定及其药敏试验分析[J].中国真菌学杂志,2006,1(3):134-138. 被引量:25
  • 2项明洁,彭奕冰,徐炜新,张华,陈华,刘明,沈韻,倪语星.白假丝酵母菌随机扩增多态DNA分型及其流行趋势分析[J].诊断学理论与实践,2007,6(1):40-42. 被引量:5
  • 3郭慧君,夏忠弟,吴高莉,周辉.耐药白念珠菌主动外排泵蛋白的功能与基因表达[J].中南大学学报(医学版),2007,32(1):183-187. 被引量:7
  • 4Rajendra Prasad,Khyati Kapoor.Multidrug Resistance in Yeast Candida[J].International Review of Cytology.2004
  • 5Mishra Nagendra Nath,Prasad Tulika,Sharma Neeraj,Payasi Anurag,Prasad Rajendra,Gupta Dwijendra K,Singh Randhir.Pathogenicity and drug resistance in Candida albicans and other yeast species. A review[].Acta microbiologica et immunologica Hungarica.2007
  • 6Chau Andrew S,Mendrick Cara A,Sabatelli Frank J,Loebenberg David,McNicholas Paul M.Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles[].Antimicrobial Agents and Chemotherapy.2004
  • 7Masakazu Niimi,Kyoko Niimi,Yukie Takano,Ann R Holmes,Frank J Fischer,Yoshimasa Uehara,Richard D Cannon.Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance[].Journal of Antimicrobial Chemotherapy.2004
  • 8Michael A. Pfaller,Gary J. Moet,Shawn A. Messer,Ronald N. Jones,Mariana Castanheira.Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)[].Journal of Clinical Microbiology.2011
  • 9Pfaller M A,Diekema D J,Gibbs D L,Newell V A,Ellis D,Tullio V,Rodloff A,Fu W,Ling T A.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion[].Journal of Clinical Microbiology.2010
  • 10Maebashi K,Niimi M,Kudoh M,Fischer F J,Makimura K,Niimi K,Piper R J,Uchida K,Arisawa M,Cannon R D,Yamaguchi H.Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients[].The Journal of antimicrobial chemotherapy.2001

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部